| Indicators | Browse All

Grifols, S.A. (GRFS)

Healthcare | Drug Manufacturers - General | Barcelona, Spain | NasdaqGS
7.69 USD -0.13 (-1.662%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 7.69

Short-term:★★⯪☆☆Long-term:★★⯪☆☆Dividends:★★★☆☆
Hot Take | Aug. 22, 2026, 3:02 a.m. EDT

The investment case for Grifols remains fundamentally conflicted, creating a stalemate between attractive valuation metrics and a lack of confirmed momentum. On the fundamental side, the company trades at a forward P/E of roughly 5.6x with a 3.5% yield, offering a compelling margin of safety if the business stabilizes. However, the multi-year price trajectory tells a different story; despite a recent year-over-year gain, the asset has lost nearly 38% of its value over the last nine years, and the market has consistently punished the stock during periods of uncertainty. This historical drag prevents a 'strong buy' classification despite the cheap valuation. The options market confirms this hesitation. There is a heavy concentration of open interest at the 9.0 and 10.0 strike levels for calls, acting as a psychological resistance zone, while put buyers are aggressively establishing floors at 6.0 and 7.0. This structure suggests traders expect the stock to oscillate within a tight band rather than break out to new highs. With the statistical forecast showing zero directional bias and the recent price action hovering near the 50-day moving average without a clear trend, the prudent approach is to remain neutral. The yield provides a cushion, but the lack of a clear catalyst to reverse the long-term downtrend keeps the overall conviction moderate.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.038027
AutoTheta0.038891
AutoETS0.038944
MSTL0.039144

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 48%
H-stat 1.45
Ljung-Box p 0.000
Jarque-Bera p 0.219
Excess Kurtosis -0.64
Attribute Value
Sector Healthcare
Ex Dividend Date 2026-07-01
Last Dividend Date 2026-07-01
Debt to Equity Ratio 117.243
Revenue per Share 5.424
Market Cap 5,233,655,808
Trailing P/E 10.12
Forward P/E 5.39
Beta 1.19
Profit Margins 6.09%
Website https://www.grifols.com

As of Aug. 22, 2026, 3:02 a.m. EDT: Speculators are positioning for a range-bound outcome with a distinct skew toward downside protection. Call open interest is heavily concentrated at strikes 9.0 and 10.0, suggesting a ceiling expectation, while put open interest is massive at strikes 6.0 and 7.0, indicating a significant floor. The recent surge in ATM put volume combined with elevated implied volatility on deep OTM puts suggests active hedging against a potential drop below the current price, rather than aggressive bullish speculation.


Dividend Data

Yield Summary
Last Yield 1yr Yield 3yr Avg 5yr Avg
1.31% 1.31% 0.98% 0.59%
Dividend History
Date Dividend Yield %
2026-07-02 0.0940 1.312849
2025-08-12 0.1730 1.632075
2021-06-03 0.4560 2.720764
2020-10-30 0.2010 1.183746
2019-12-02 0.2200 0.971302
2019-06-07 0.1740 0.915308
2018-11-30 0.2280 1.156187
2018-06-01 0.2510 1.142987
2017-12-01 0.2120 0.954955
2017-05-30 0.1630 0.771415
2016-12-05 0.1910 1.294915
2016-06-02 0.1590 0.944181
2015-12-10 0.1850 1.121212
2015-06-08 0.1675 1.098361
2014-12-04 0.1565 0.904886
2014-06-05 0.1435 0.672289
2013-06-05 0.1295 0.966418
2013-05-29 0.0065 0.048148
Additional Data
dividendRate 0.28
dividendYield 3.6
exDividendDate 2026-07-02
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
lastDividendValue 0.094
lastDividendDate 2026-07-02
dividendDate 2026-07-09

Info Dump

Attribute Value
52 Week Change -0.19214875
Address1 Parque Empresarial Can Sant Joan
Address2 Avinguda de la Generalitat, 152-158 Sant Cugat del Valles
All Time High 25.73
All Time Low 4.542857
Ask 8.83
Ask Size 1
Average Daily Volume10 Day 388,630
Average Daily Volume3 Month 641,001
Average Volume 641,001
Average Volume10Days 388,630
Beta 1.192
Bid 6.73
Bid Size 1
Book Value 4.759505
City Barcelona
Compensation As Of Epoch Date 1,767,139,200
Country Spain
Crypto Tradeable 0
Currency USD
Current Price 7.69
Current Ratio 2.373
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 7.885
Day Low 7.68
Debt To Equity 117.243
Dividend Date 1,783,555,200
Dividend Rate 0.28
Dividend Yield 3.6
Earnings Call Timestamp End 1,785,268,800
Earnings Call Timestamp Start 1,785,268,800
Earnings Growth 0.329
Earnings Quarterly Growth 0.313
Earnings Timestamp 1,785,268,800
Earnings Timestamp End 1,785,268,800
Earnings Timestamp Start 1,785,268,800
Ebitda 1,645,230,976
Ebitda Margins 0.2217
Enterprise To Ebitda 13.202
Enterprise To Revenue 2.927
Enterprise Value 21,720,332,288
Eps Current Year 1.17687
Eps Forward 1.42546
Eps Trailing Twelve Months 0.76
Esg Populated 0
Ex Dividend Date 1,782,950,400
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 34 938 00 80 00
Fifty Day Average 7.6286
Fifty Day Average Change 0.061399937
Fifty Day Average Change Percent 0.008048651
Fifty Two Week Change Percent -19.214874
Fifty Two Week High 10.23
Fifty Two Week High Change -2.5399995
Fifty Two Week High Change Percent -0.2482893
Fifty Two Week Low 6.96
Fifty Two Week Low Change 0.73
Fifty Two Week Low Change Percent 0.10488506
Fifty Two Week Range 6.96 - 10.23
Financial Currency EUR
First Trade Date Milliseconds 1,307,021,400,000
Five Year Avg Dividend Yield 2.4
Float Shares 836,243,242
Forward Eps 1.42546
Forward P E 5.3947496
Free Cashflow 572,923,392
Full Exchange Name NasdaqGS
Full Time Employees 25,258
Fullday Change -0.13
Fullday Change Percent -1.66241
Fullday Price 7.69
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.37789002
Gross Profits 2,804,323,072
Has Pre Post Market Data 1
Held Percent Insiders 0.0
Held Percent Institutions 0.57137
Implied Shares Outstanding 680,579,407
Industry Drug Manufacturers - General
Industry Disp Drug Manufacturers - General
Industry Key drug-manufacturers-general
Is Earnings Date Estimate 0
Language en-US
Last Dividend Date 1,782,950,400
Last Dividend Value 0.094
Last Fiscal Year End 1,767,139,200
Last Split Date 1,451,865,600
Last Split Factor 2:1
Long Business Summary Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.
Long Name Grifols, S.A.
Market us_market
Market Cap 5,233,655,808
Market State CLOSED
Max Age 86,400
Message Board Id finmb_734865
Most Recent Quarter 1,782,777,600
Net Income To Common 452,000,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 6,998,819,325
Number Of Analyst Opinions 2
Open 7.83
Operating Cashflow 1,091,000,064
Operating Margins 0.15902
Payout Ratio 0.36830002
Peg Ratio 0.19
Phone 34 935 71 22 00
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 7.69
Post Market Time 1,787,947,804
Previous Close 7.82
Price Eps Current Year 6.5342817
Price Hint 2
Price To Book 1.6157143
Price To Sales Trailing12 Months 0.70524937
Profit Margins 0.06091
Quick Ratio 0.697
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.13
Regular Market Change Percent -1.66241
Regular Market Day High 7.885
Regular Market Day Low 7.68
Regular Market Day Range 7.68 - 7.885
Regular Market Open 7.83
Regular Market Previous Close 7.82
Regular Market Price 7.69
Regular Market Time 1,787,947,201
Regular Market Volume 322,332
Return On Assets 0.04231
Return On Equity 0.06933
Revenue Growth -0.009
Revenue Per Share 5.424
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 258,223,442
Shares Percent Shares Out 0.0052
Shares Short 3,455,645
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 6,340,082
Short Name Grifols, S.A.
Short Ratio 5.29
Source Interval 15
Symbol GRFS
Target High Price 11.73
Target Low Price 10.0
Target Mean Price 10.865
Target Median Price 10.865
Total Cash 537,000,000
Total Cash Per Share 0.395
Total Debt 9,356,000,256
Total Revenue 7,421,000,192
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 0.76
Trailing P E 10.118422
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 8.30725
Two Hundred Day Average Change -0.61724997
Two Hundred Day Average Change Percent -0.07430256
Type Disp Equity
Volume 322,332
Website https://www.grifols.com
Zip 8,174